Abbott Laboratories Revenue 2006-2019 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending March 31, 2019 was $7.535B, a 1.96% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending March 31, 2019 was $30.723B, a 8.01% increase year-over-year.
  • Abbott Laboratories annual revenue for 2018 was $30.578B, a 11.64% increase from 2017.
  • Abbott Laboratories annual revenue for 2017 was $27.39B, a 31.35% increase from 2016.
  • Abbott Laboratories annual revenue for 2016 was $20.853B, a 2.2% increase from 2015.
Abbott Laboratories Annual Revenue
(Millions of US $)
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
2008 $29,528
2007 $25,914
2006 $22,476
2005 $22,338
Abbott Laboratories Quarterly Revenue
(Millions of US $)
Q1 2019 $7,535
Q4 2018 $7,765
Q3 2018 $7,656
Q2 2018 $7,767
Q1 2018 $7,390
Q4 2017 $7,589
Q3 2017 $6,829
Q2 2017 $6,637
Q1 2017 $6,335
Q4 2016 $5,333
Q3 2016 $5,302
Q2 2016 $5,333
Q1 2016 $4,885
Q4 2015 $5,188
Q3 2015 $5,150
Q2 2015 $5,170
Q1 2015 $4,897
Q4 2014 $5,356
Q3 2014 $5,079
Q2 2014 $5,057
Q1 2014 $4,755
Q4 2013 $4,008
Q3 2013 $4,825
Q2 2013 $5,446
Q1 2013 $5,378
Q4 2012 $3,188
Q3 2012 $5,265
Q2 2012 $5,313
Q1 2012 $5,284
Q4 2011 $10,377
Q3 2011 $9,817
Q2 2011 $9,616
Q1 2011 $9,041
Q4 2010 $9,968
Q3 2010 $8,675
Q2 2010 $8,826
Q1 2010 $7,698
Q4 2009 $8,790
Q3 2009 $7,761
Q2 2009 $7,495
Q1 2009 $6,718
Q4 2008 $7,950
Q3 2008 $7,498
Q2 2008 $7,314
Q1 2008 $6,766
Q4 2007 $7,221
Q3 2007 $6,377
Q2 2007 $6,371
Q1 2007 $5,946
Q4 2006 $6,821
Q3 2006 $5,574
Q2 2006 $5,501
Q1 2006 $4,580
Q4 2005 $6,047
Q3 2005 $5,384
Q2 2005 $5,524
Q1 2005 $5,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $130.875B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Boston Scientific (BSX) United States $48.570B 23.60
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00